Your browser doesn't support javascript.
loading
Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments.
Suzuki, Hiroyuki; Iwamoto, Hideki; Nakano, Masahito; Nakamura, Toru; Masuda, Atsutaka; Sakaue, Takahiko; Tanaka, Toshimitsu; Nakano, Dan; Kuromatsu, Ryoko; Niizeki, Takashi; Okamura, Shusuke; Shimose, Shigeo; Shirono, Tomotake; Noda, Yu; Kamachi, Naoki; Yano, Hirohisa; Kawaguchi, Atsushi; Koga, Hironori; Torimura, Takuji.
Afiliação
  • Suzuki H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; Iwamoto Internal Medicine Clinic, Kitakyushu, Japan. Electronic address: iwamoto_hideki@med.kurume-u.ac.jp.
  • Nakano M; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Nakamura T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Masuda A; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Sakaue T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Tanaka T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Nakano D; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kuromatsu R; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Niizeki T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Okamura S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Shirono T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Noda Y; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kamachi N; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Yano H; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
  • Kawaguchi A; Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Koga H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Torimura T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Transl Oncol ; 14(11): 101201, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34388691
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão